In summary, our current observations suggest a novel mechanism in which Cdc42 signaling in the CPu, regulated by dopamine D2R, contributes to deficits in spine abnormities and motor coordination and cognition, characteristic of Parkinson's disease. This evidence concerns the gene CDC42 and Parkinson disease.